The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Given Imaging's revenues will expand 8.3% and EPS will grow 25.0%.
The average estimate for revenue is $48.2 million. On the bottom line, the average EPS estimate is $0.20.
Last quarter, Given Imaging notched revenue of $40.6 million. GAAP reported sales were 2.9% lower than the prior-year quarter's $41.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
Last quarter, non-GAAP EPS came in at $0.05. GAAP EPS were -$0.01 for Q1 against $0.01 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the preceding quarter, gross margin was 77.1%, 150 basis points better than the prior-year quarter. Operating margin was 0.2%, 80 basis points worse than the prior-year quarter. Net margin was -0.5%, 100 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $193.7 million. The average EPS estimate is $0.69.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 123 members out of 138 rating the stock outperform, and 15 members rating it underperform. Among 26 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 23 give Given Imaging a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Given Imaging is outperform, with an average price target of $20.33.
Is Given Imaging the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Given Imaging to My Watchlist.